Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Peak Bio (PKBO)
OTHER OTC:PKBO
Peak Bio (PKBO) Stock Price & Analysis
6 Followers
PKBO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.02 - $1.00
Previous Close$0.04
Volume94.00
Average Volume (3M)5.00K
Market Cap
$117.69K
Enterprise Value$4.16M
Total Cash (Recent Filing)$214.37K
Total Debt (Recent Filing)$4.25M
Price to Earnings (P/E)>-0.1
Beta0.69
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.41
Shares Outstanding21,903,843
10 Day Avg. Volume10
30 Day Avg. Volume5,005
Standard Deviation0.58
R-Squared0.00210
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)-0.01
Price to Sales (P/S)0.19
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.69
Enterprise Value/Gross Profit6.84
Enterprise Value/Ebitda-0.17
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Peak Bio News
PremiumCompany Announcements
Peak Bio’s Strategic Merger with Akari Therapeutics
PremiumCompany Announcements
Peak Bio Raises Over $2M Through Convertible Notes
PremiumCompany Announcements
Peak Bio Raises Capital via Convertible Promissory Notes
Ownership Overview
45.47% Insiders
0.00% Mutual Funds
2.20% Other Institutional Investors
52.34% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PKBO FAQ
What was Peak Bio’s price range in the past 12 months?
Peak Bio lowest stock price was $0.02 and its highest was $1.00 in the past 12 months.
What is Peak Bio’s market cap?
Currently, no data Available
When is Peak Bio’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Peak Bio’s earnings last quarter?
Currently, no data Available
Is Peak Bio overvalued?
According to Wall Street analysts Peak Bio’s price is currently Overvalued.
Does Peak Bio pay dividends?
Peak Bio does not currently pay dividends.
What is Peak Bio’s EPS estimate?
Peak Bio’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Peak Bio have?
Peak Bio has 22,632,843 shares outstanding.
What happened to Peak Bio’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Peak Bio?
Among the largest hedge funds holding Peak Bio’s share is Saba Capital Management. It holds Peak Bio’s shares valued at N/A.
---
Peak Bio Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
Peak Bio
Ignyte Acquisition Corp is a blank check company.
---
---